ADIPOQ and metabolic dysfunction-associated steatotic liver disease: However, there is significant heterogeneity among studies, and the importance of including biopsy-proven healthy controls is underlined; most differences in adiponectin between individuals with NAFLD and controls were observed when the controls were not subjected to liver biopsy (37).